The only way to retain love is to give it away.
Thought of the Week: True Strength
September 10, 2025
Thought of the Week: Retaining Love
080914
Related:
Thought of the Week: The Sea is So Wide
September 2, 2025
Thought of the Week: Peace of Mind
August 24, 2025
Strength is in Our Soul and Spirit
August 12, 2025
Thought of the Week: One’s Attitude
July 27, 2025
Thought of the Week: What We Give
July 17, 2025
Edited by:
P. Berger
Caring for dementias such as Alzheimer's among family and friends, Peter committed to help preserve the dignity of people affected by Alzheimer's. AlzheimersWeekly.com is the fruit of that commitment.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Advocacy
November is Alzheimer’s Awareness Month
For Alzheimer’s Awareness Month, spread this video to raise awareness of simple things you can do to prevent Alzheimer’s.
No Comments
Diagnosis:Related-Conditions
Aphasia in Dementia: Word Jumbles
Aphasia affects a person’s ability to communicate. It affects language functions, such as speaking, understanding what others say, and naming common objects. Learn its causes, types and a few tips.
14 Comments
Care Tips
Turn “No” into “Yes” in Dementia
CARE-TIPS VIDEO + ARTICLE: A common frustration in Alzheimer’s is the propensity to say “no” to just about everything. Often, this is triggered by physical
No Comments
Drugs
Lecanemab’s Rare and Manageable Side Effects
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On
I agree